Lack of significant modifying effect of arctiin on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats

Cancer Letters

Volumn 222, Issue 2, 2005, Pages 145-151

  Zeng, Yu ^a   Yokohira, Masanao ^a   Takeuchi, Hijiri ^a   Saoo, Kousuke ^a   Yamakawa, Keiko ^a   Matsuda, Yoko ^a   Hosokawa, Kyoko ^a   Li, Jia Qing ^a   Ikeda, Mico ^a   Imaida, Katsumi ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Arctiin; Chemoprevention; Endocrine disruptor compounds; Prostate cancer; SV 40 T antigen transgenic rat

Indexed keywords

ARCTIIN; ENDOCRINE DISRUPTOR; LIGNAN; PROBASIN; SEX HORMONE; VIRUS T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCTIUM; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DIET; DISEASE COURSE; DRUG EFFECT; DRUG ISOLATION; EMBRYO; ENVIRONMENT; EVALUATION; EXAMINATION; FEMALE; HISTOPATHOLOGY; MALE; NONHUMAN; PLANT SEED; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN SYNTHESIS; RANDOMIZATION; RAT; SIMIAN VIRUS 40; SOYBEAN; STATISTICAL SIGNIFICANCE; STEROIDOGENESIS; TRANSGENIC ANIMAL;

ANIMALIA; ARCTIUM LAPPA; GLYCINE MAX;

EID: 18044370438     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.09.026     Document Type: Article

References (31)

1. R.T. Greenlee, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics, 2000 CA Cancer J. Clin. 50 2000 7 33
2. S. Franceschi, and C. La Vecchia Cancer epidemiology in the elderly Crit. Rev. Oncol. Hematol. 39 2001 219 226
3. M. Blanchere, I. Berthaut, M.C. Portois, C. Mestayer, and I. Mowszowicz Hormonal regulation of the androgen receptor expression in human prostatic cells in culture J. Steroid Biochem. Mol. Biol. 66 1998 319 326
4. B.G. Mobbs, I.E. Johnson, J.G. Connolly, and J. Thompson Concentration and cellular distribution of androgen receptor in human prostatic neoplasia: can estrogen treatment increase androgen receptor content? J. Steroid Biochem. 19 1983 1279 1290
5. R.J. Moore, J.M. Gazak, and J.D. Wilson Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol J. Clin. Invest. 63 1979 351 357
6. P. Ofner, M.C. Bosland, and R.L. Vena Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes Toxicol. Appl. Pharmacol. 112 1992 300 309
7. K.M. Lau, I. Leav, and S.M. Ho Rat estrogen receptor-alpha and -beta, and progesterone receptor mRNA expression in various prostatic lobes and microdissected normal and dysplastic epithelial tissues of the Noble rats Endocrinology 139 1998 424 427
8. I. Leav, F.B. Merk, P.W. Kwan, and S.M. Ho Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats Prostate 15 1989 23 40
9. I. Leav, S.M. Ho, P. Ofner, F.B. Merk, P.W. Kwan, and D. Damassa Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats J. Natl Cancer Inst. 80 1988 1045 1053
10. R. Nilsson Endocrine modulators in the food chain and environment Toxicol. Pathol. 28 2000 420 431
11. K. Fukamachi, B.S. Han, C.K. Kim, N. Takasuka, Y. Matsuoka, and E. Matsuda Possible enhancing effects of atrazine and nonylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats Cancer Sci. 95 2004 404 410
12. H. Tsuda, A. Naito, C.K. Kim, K. Fukamachi, H. Nomoto, and M.A. Moore Carcinogenesis and its modification by environmental endocrine disruptors: in vivo experimental and epidemiological findings Jpn. J. Clin. Oncol. 33 2003 259 270
13. L. Denis, M.S. Morton, and K. Griffiths Diet and its preventive role in prostatic disease Eur. Urol. 35 1999 377 387
14. H. Adlercreutz Phytoestrogens and prevention of cancer H. Ohigashi T. Osawa Food Factors for Cancer Prevention 1997 Springer Berlin 587 592
15. K.R. Price, and G.R. Fenwick Naturally occurring oestrogens in foods - a review Food Addit. Contam. 2 1985 73 106
16. X. Lin, J.R. Gingrich, W. Bao, J. Li, Z.A. Haroon, and W. Demark-Wahnefried Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice Urology 60 2002 919 924
17. B.S. Yu, X.P. Yan, J. Xiong, and Q. Xin Simultaneous determination of chlorogenic acid, forsythin and arctiin in Chinese traditional medicines preparation by reversed phase-HPLC Chem. Pharm. Bull. (Tokyo) 51 2003 421 424
18. H. Adlercreutz, B.R. Goldin, S.I. Gorbach, K.A. Hockerstedt, S. Watanabe, and E.K. Hamalainen Soybean phytoestrogen intake and cancer risk J. Nutr. 125 Suppl. 3 1995 757 770
19. L.H. Xie, E.M. Ahn, T. Akao, A.A. Abdel-Hafez, N. Nakamura, and M. Hattori Transformation of arctiin to estrogenic and antiestrogenic substances by human intestinal bacteria Chem. Pharm. Bull. (Tokyo) 51 2003 378 384
20. T. Kato, M. Hirose, S. Takahashi, R. Hasegawa, T. Kohno, and S. Nishibe Effects of the lignan, arctiin, on 17-beta ethinyl estradiol promotion of preneoplastic liver cell foci development in rats Anticancer Res. 18 1998 1053 1057
21. M. Asamoto, N. Hokaiwado, Y.M. Cho, S. Takahashi, Y. Ikeda, K. Imaida, and T. Shirai Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent Cancer Res. 61 2001 4693 4700
22. M. Asamoto, T. Ochiya, H. Toriyama-Baba, T. Ota, T. Sekiya, M. Terada, and H. Tsuda Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis Carcinogenesis 21 2000 243 249
23. T. Watanabe, Y. Katsura, A. Yoshitake, H. Masataki, and T. Mori Image processors for analytical pathology J. Toxicol. Pathol. 7 1994 353 361
24. S.B. Shappell, G.V. Thomas, R.L. Roberts, R. Herbert, M.M. Ittmann, and M.A. Rubin Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the mouse models of human cancer consortium prostate pathology committee Cancer. Res. 64 2004 2270 2305
25. M.S. Steiner, and S. Raghow Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk World J. Urol. 21 2003 31 36
26. M. Hirose, T. Yamaguchi, C. Lin, N. Kimoto, M. Futakuchi, and T. Kono Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats Cancer Lett. 155 2000 79 88
27. Y.M. Cho, S. Takahashi, M. Asamoto, S. Suzuki, S. Inaguma, N. Hokaiwado, and T. Shirai Age-dependent histopathological findings in the prostate of probasin/SV40 T antigen transgenic rats: lack of influence of carcinogen or testosterone treatment Cancer Sci. 94 2003 153 157
28. Y. Kitamura, M. Yamagishi, K. Okazaki, H.Y. Son, T. Imazawa, and A. Nishikawa Lack of significant inhibitory effects of a plant lignan tracheloside on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary carcinogenesis in female Sprague-Dawley rats Cancer Lett. 200 2003 133 139
29. N.M. Greenberg, F. DeMayo, M.J. Finegold, D. Medina, W.D. Tilley, and J.O. Aspinall Prostate cancer in a transgenic mouse Proc. Natl Acad. Sci. USA 92 1995 3439 3443
30. J.R. Gingrich, R.J. Barrios, R.A. Morton, B.F. Boyce, F.J. DeMayo, and M.J. Finegold Metastatic prostate cancer in a transgenic mouse Cancer Res. 56 1996 4096 4102
31. J.R. Gingrich, R.J. Barrios, M.W. Kattan, H.S. Nahm, M.J. Finegold, and N.M. Greenberg Androgen-independent prostate cancer progression in the TRAMP model Cancer Res. 57 1997 4687 4691